• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阳离子固体脂质纳米粒的 pDNA 缩合能力和体外基因传递特性。

pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.

机构信息

University of Modena and Reggio Emilia, Department of Pharmaceutical Sciences, Via Campi 183, 41100 Modena, Italy.

出版信息

Int J Pharm. 2010 Apr 15;389(1-2):254-61. doi: 10.1016/j.ijpharm.2010.01.030. Epub 2010 Jan 25.

DOI:10.1016/j.ijpharm.2010.01.030
PMID:20100555
Abstract

Cationic solid lipid nanoparticles (SLN) are promising nonviral gene delivery carriers suitable for systemic administration. The objective of this study was to investigate the relationship between the composition of cationic SLN and their ability to condense plasmid DNA (pDNA) and to transfer it in neuroblastoma cells. The SLN were prepared by using stearic acid and stearylamine as lipid core along with Esterquart 1 (EQ1) or Protamine obtaining two samples (SLN-EQ1 and SLN-Protamine, respectively). The cationic SLN were freeze-dried after preparation and their physical-chemical properties, including the surface composition and the transfection efficiency were investigated. The results showed that the two samples had similar size, zeta potential and pDNA binding properties but SLN-Protamine were able to condense pDNA more efficaciously than SLN-EQ1 forming smaller and less positive complexes. SLN-Protamine:pDNA complexes demonstrated to be less cytotoxic and more efficient in the transfection of Na1300 cell line than SLN-EQ1:pDNA. These findings were attributed to the different surface composition of the two samples and in particular to the localization of the Protamine on the surface of the particle while EQ1 in the lipid core. In conclusion the results here suggest that not only the z-potential but also the surface composition may affect the pDNA condensation proprieties and thus the transfection efficiency of nonviral gene nanocarriers.

摘要

阳离子固体脂质纳米粒 (SLN) 是一种很有前途的非病毒基因传递载体,适合全身给药。本研究的目的是研究阳离子 SLN 的组成与其凝聚质粒 DNA(pDNA)的能力以及在神经母细胞瘤细胞中转移的能力之间的关系。使用硬脂酸和硬脂胺作为脂质核心,与 Esterquart 1(EQ1)或鱼精蛋白一起制备 SLN,得到两种样品(SLN-EQ1 和 SLN-鱼精蛋白)。制备后,将阳离子 SLN 冷冻干燥,并研究其物理化学性质,包括表面组成和转染效率。结果表明,两种样品具有相似的粒径、Zeta 电位和 pDNA 结合特性,但 SLN-鱼精蛋白比 SLN-EQ1 更有效地凝聚 pDNA,形成更小、更负的复合物。与 SLN-EQ1:pDNA 相比,SLN-鱼精蛋白:pDNA 复合物的细胞毒性更小,对 Na1300 细胞系的转染效率更高。这些发现归因于两种样品的表面组成不同,特别是鱼精蛋白在颗粒表面的定位,而 EQ1 在脂质核心中。总之,结果表明,不仅 Zeta 电位,而且表面组成也可能影响 pDNA 凝聚特性,从而影响非病毒基因纳米载体的转染效率。

相似文献

1
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.阳离子固体脂质纳米粒的 pDNA 缩合能力和体外基因传递特性。
Int J Pharm. 2010 Apr 15;389(1-2):254-61. doi: 10.1016/j.ijpharm.2010.01.030. Epub 2010 Jan 25.
2
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter.含鱼精蛋白的阳离子固体脂质纳米粒的核定位作为转染促进剂。
Eur J Pharm Biopharm. 2010 Nov;76(3):384-93. doi: 10.1016/j.ejpb.2010.07.012. Epub 2010 Aug 4.
3
Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector.设计灵活性对阳离子 SLN 作为非病毒基因载体的体外行为的影响。
Int J Pharm. 2013 Jan 20;440(2):161-9. doi: 10.1016/j.ijpharm.2012.08.055. Epub 2012 Sep 11.
4
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier.鱼精蛋白用量对作为基因纳米载体的阳离子 SLN 转染性能的作用。
Drug Deliv. 2012 Jan;19(1):1-10. doi: 10.3109/10717544.2011.621989. Epub 2011 Nov 9.
5
Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery.阴离子脂质纳米粒/鱼精蛋白/DNA 的三元纳米粒用于基因传递。
Int J Pharm. 2010 Jun 15;392(1-2):224-31. doi: 10.1016/j.ijpharm.2010.03.025. Epub 2010 Mar 15.
6
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid.无需冷冻保护剂冻干的可再分散阳离子固体脂质纳米粒(SLNs):表征及其结合pEGFP质粒的能力
Eur J Pharm Biopharm. 2007 Sep;67(2):320-8. doi: 10.1016/j.ejpb.2007.02.006. Epub 2007 Feb 14.
7
Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.新型阳离子固体脂质纳米粒增强了p53基因向肺癌细胞的转染。
Eur J Pharm Biopharm. 2008 Mar;68(3):545-54. doi: 10.1016/j.ejpb.2007.07.011. Epub 2007 Aug 8.
8
Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery.含有合成单尾脂质作为基因递送修饰剂的新型阳离子固体脂质纳米粒。
Nanotechnology. 2009 May 27;20(21):215102. doi: 10.1088/0957-4484/20/21/215102. Epub 2009 May 5.
9
Employment of cationic solid-lipid nanoparticles as RNA carriers.阳离子固体脂质纳米粒作为RNA载体的应用。
Bioconjug Chem. 2007 Mar-Apr;18(2):302-8. doi: 10.1021/bc0601166. Epub 2007 Jan 25.
10
Cationic star polymers consisting of alpha-cyclodextrin core and oligoethylenimine arms as nonviral gene delivery vectors.由α-环糊精核心和低聚乙二胺臂组成的阳离子星形聚合物作为非病毒基因传递载体。
Biomaterials. 2007 Jul;28(21):3245-54. doi: 10.1016/j.biomaterials.2007.03.033. Epub 2007 Apr 12.

引用本文的文献

1
Exploring the potential of nanomedicine for gene therapy across the physicochemical and cellular barriers.探索纳米医学跨越物理化学和细胞屏障用于基因治疗的潜力。
Funct Integr Genomics. 2024 Sep 28;24(5):177. doi: 10.1007/s10142-024-01459-z.
2
The Astonishing Accomplishment of Biological Drug Delivery using Lipid Nanoparticles: An Ubiquitous Review.脂质纳米粒在生物药物传递方面的惊人成就:全面综述。
Curr Pharm Biotechnol. 2024;25(15):1952-1968. doi: 10.2174/0113892010268824231122041237.
3
Comparative Analysis of the Physicochemical and Biological Characteristics of Freeze-Dried PEGylated Cationic Solid Lipid Nanoparticles.
冻干聚乙二醇化阳离子固体脂质纳米粒的物理化学和生物学特性的比较分析
Pharmaceuticals (Basel). 2023 Nov 9;16(11):1583. doi: 10.3390/ph16111583.
4
Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery.影响皮肤渗透的物理化学和生物药剂学方面以及固体脂质纳米粒和纳米结构脂质载体在皮肤给药中的作用。
Heliyon. 2022 Feb 11;8(2):e08938. doi: 10.1016/j.heliyon.2022.e08938. eCollection 2022 Feb.
5
Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo.靶向信号转导和转录激活因子3的新型纳米复合物在体内显示出有前景的抗卵巢癌作用。
Onco Targets Ther. 2020 Jun 8;13:5069-5082. doi: 10.2147/OTT.S247398. eCollection 2020.
6
Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.克服基因传递障碍:非病毒载体的生理学考量
Trends Biotechnol. 2016 Feb;34(2):91-105. doi: 10.1016/j.tibtech.2015.11.004. Epub 2015 Dec 23.
7
Influence of cationic lipid concentration on properties of lipid-polymer hybrid nanospheres for gene delivery.阳离子脂质浓度对用于基因递送的脂质-聚合物杂化纳米球性质的影响。
Int J Nanomedicine. 2015 Sep 2;10:5367-82. doi: 10.2147/IJN.S87120. eCollection 2015.
8
Nanoparticle-based technologies for retinal gene therapy.用于视网膜基因治疗的基于纳米颗粒的技术。
Eur J Pharm Biopharm. 2015 Sep;95(Pt B):353-67. doi: 10.1016/j.ejpb.2014.12.028. Epub 2015 Jan 12.
9
Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives.脂质纳米颗粒作为用于抗病毒感染的RNA干扰载体:现状与未来展望
Biomed Res Int. 2014;2014:161794. doi: 10.1155/2014/161794. Epub 2014 Aug 12.